Obstructive Sleep Apnea Linked to Poor Muscle Quality and Higher Fracture Risk

How Does Obstructive Sleep Apnea Affect Muscles and Bones?

Obstructive sleep apnea is characterized by repeated episodes of partial or complete upper-airway collapse during sleep, leading to intermittent drops in blood oxygen and frequent micro-arousals. While OSA is best known for causing daytime sleepiness and cardiovascular strain, researchers at Ben-Gurion University of the Negev and Soroka University Medical Center report that patients with OSA also exhibit measurably poorer skeletal muscle quality and elevated fracture risk compared with matched controls. The study, published in the journal Sleep and Breathing, draws on imaging and clinical data to show that the damage extends well beyond the airway.

The proposed mechanisms are biologically plausible. Chronic intermittent hypoxia triggers systemic inflammation and oxidative stress, both of which are known to degrade muscle fibers and disrupt bone remodeling. Fragmented sleep reduces the nightly surges of growth hormone and testosterone that support anabolic muscle maintenance, while elevated cortisol tips the balance toward catabolism. Add to this a tendency toward physical inactivity and obesity in many OSA patients, and the conditions for sarcopenia — age-related loss of muscle mass and quality — and osteoporosis become alarmingly favorable.

Why Does This Matter for Everyday Patients?

Fractures are not a minor concern. Hip fractures in older adults carry a well-documented one-year mortality that international data places in the range of 15 to 30 percent, and even non-hip fragility fractures are associated with long-term loss of mobility and independence. If OSA meaningfully contributes to that risk trajectory, treating it effectively is not just about reducing daytime sleepiness — it may help preserve the musculoskeletal system that keeps people upright and active into older age.

The clinical implications are practical. Clinicians who treat OSA may need to screen for sarcopenia and bone density loss, particularly in patients over 50 with long-standing untreated disease. Conversely, specialists in geriatrics, endocrinology, and orthopedics evaluating unexplained muscle weakness or unusual fracture patterns should consider asking about snoring, witnessed apneas, and daytime sleepiness. Resistance training, vitamin D and calcium optimization, and — where indicated — CPAP therapy may all play a role in protecting bone and muscle in this population.

Can Treating Sleep Apnea Protect Musculoskeletal Health?

Continuous positive airway pressure (CPAP) remains the first-line treatment for moderate to severe OSA and is well established for improving daytime alertness, blood pressure, and cardiovascular outcomes. Whether CPAP directly reverses muscle quality deficits or lowers fracture risk has not yet been definitively shown in large randomized trials, and the Ben-Gurion researchers are careful to frame their findings as an association rather than proof of causation. Still, by restoring normal oxygenation and consolidating sleep, CPAP addresses two of the most plausible mechanisms by which OSA damages muscle and bone.

Alternative therapies are also relevant. Mandibular advancement devices, positional therapy, weight reduction, and — for selected patients — hypoglossal nerve stimulation can all reduce apnea severity. Pairing any of these with structured resistance exercise, adequate protein intake, and bone-health monitoring may offer the best chance of protecting long-term musculoskeletal function. Patients who suspect they have OSA should seek a formal sleep evaluation rather than self-diagnose, since untreated disease carries risks that now appear to reach well beyond the cardiovascular system.